Autism spectrum disorder (ASD) has a prevalence of 1 in 68 children – a 30% increase since 2012 according to the Center for Disease Control and Prevention (CDC). ASD was once a rare disorder but is occurring more frequently than before, as more cases are being diagnosed each year. The reason for this increase may be linked to certain ingredients found in vaccines, specifically aluminum formulated vaccines. Dr. Stephanie Seneff, a funded CMSRI researcher, has reviewed empirical data that confirms autism symptoms related to aluminum and acetaminophen exposure.
Autism and ASD can be defined as a condition characterized by impaired cognitive and social skills along with compromised immune function. The fact that ASD rates have rapidly increased over the last two decades suggests that there are environmental components that lead to its prevalence. The root cause of ASD is still unknown; however, current research is suggesting that the use of vaccines are playing a role in its development. In her review titled Empirical Data Confirm Autism Symptoms Related to
Aluminum and Acetaminophen Exposure, Dr. Seneff points out the word frequency patters in the CDCs Vaccine Adverse Events Reporting System (VAERS) database.
The VAERS is a database executed by the U.S. government that allows doctors and patients to report any adverse reactions noted in association with vaccines. After conducting a search of the words “autism” and “autistic,” Dr. Seneff plotted the word frequencies based on year and could visually graph spikes in adverse reactions with vaccines and the aforementioned keyword.
“The incidence of autism-related adverse events in the VAERS database continued to rise over the time period after the amount of thimerosal in the vaccines had been sharply reduced. We hypothesize that this unanticipated consequence is due to simultaneous increases in the aluminum content, attributed to an increased number of required vaccines, intentional addition of aluminum to achieve an adjuvant effect, as well as the likely further accumulation of aluminum as a consequence of leaching, given the new practice of storage in individual glass vials with rubber stoppers. We identified several severe adverse reactions that were much more prevalent in reports from the second decade of the data, and showed that these same symptoms were also much more prevalent for reports involving aluminum-containing vaccines compared to reports on vaccines without aluminum, over the entire data set. These symptoms include seizure, cyanosis, gaze palsy, depression, fatigue, insomnia, and death.”
With the above database available from the CDC, researchers can find specific trends relating aluminum to autism by the noted adverse reactions. As autism continues to be a prevalent disorder with more cases emerging everyday, suggesting the use of aluminum in vaccines could be a part of its cause is plausible. It could be hypothesized that if aluminum is forgone in vaccines and other products, autism cases have the potential to decrease.